key: cord-1006345-zuqc37nj
authors: Grifoni, Elisa; Valoriani, Alice; Cei, Francesco; Vannucchi, Vieri; Moroni, Federico; Pelagatti, Lorenzo; Tarquini, Roberto; Landini, Giancarlo; Masotti, Luca
title: The CALL score for predicting outcomes in patients with COVID-19
date: 2020-05-31
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa686
sha: 7855908aa15cf94532a899594bb36783ac86d736
doc_id: 1006345
cord_uid: zuqc37nj

nan

M a n u s c r i p t 2 Dear Editor, defining prognosis of patients affected by coronavirus disease 2019 due to SARS-Cov-2 infection is of utmost importance for planning appropriate setting of care and treatment. Therefore, we read with great interest the article by Ji 

Of them, 97 patients (46.2%) met criteria for progression to severe COVID-19 syndrome, and 37 patients (17.6%) died. Median CALL score was 10

6%) had lymphocyte count under 1.0 x 10 9 /L, and 54 (25.7%) had LDH over 500 U/L. Progression to severe COVID-19 syndrome increased from 27.2% in patients with CALL score ≤ 6 points to 53.0% in patients with CALL score ≥ 11 points. The predictive power of the CALL score for predicting progression to severe COVID-19 was low with an AUC of 0.622 (95% CI: 0.533-0.688) (Figure 1). Instead, the predictive power of the CALL score as prognosticator for in-hospital mortality was good (AUC 0.768, 95% CI: 0.705-0.823). In conclusion, in our COVID-19 population the CALL score seems to be a good prognosticator for in-hospital mortality

Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score

A c c e p t e d M a n u s c r i p t 4